Insights

Specialized Pain Management ZARS Pharma’s focus on topical anesthetics for pain management in medical and cosmetic procedures positions it as a key partner for clinics, hospitals, and dermatology practices seeking effective local anesthesia solutions.

Proprietary Technology Solutions With innovative delivery technologies like CHADD and Peel, ZARS offers differentiated products that can appeal to healthcare providers looking for advanced, safe, and reliable anesthetic options.

Growing Product Portfolio Having two FDA-approved products with additional pipeline developments presents opportunities for expanding into new procedural markets such as cosmetic, dermatologic, and minor surgical procedures.

Market Expansion Potential Partnerships like EuroCept for Europe demonstrate ZARS’s potential to scale commercialization efforts across international markets, providing avenues for sales growth.

Competitive Positioning Operating in a niche with limited direct competitors, ZARS’s innovative topical formulations offer unique selling propositions that can be leveraged to gain a competitive edge in the pain management and dermatology segments.

ZARS Pharma Tech Stack

Media & News

ZARS Pharma's Email Address Formats

ZARS Pharma uses at least 1 format(s):
ZARS Pharma Email FormatsExamplePercentage
FLast@zars.comJDoe@zars.com
39%
Last@zars.comDoe@zars.com
11%
FLast@zars.comJDoe@zars.com
39%
Last@zars.comDoe@zars.com
11%

Frequently Asked Questions

What is ZARS Pharma's phone number?

Minus sign iconPlus sign icon
You can contact ZARS Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ZARS Pharma's official website and social media links?

Minus sign iconPlus sign icon
ZARS Pharma's official website is zars.com and has social profiles on LinkedIn.

How much revenue does ZARS Pharma generate?

Minus sign iconPlus sign icon
As of December 2025, ZARS Pharma's annual revenue is estimated to be $33M.

What is ZARS Pharma's SIC code NAICS code?

Minus sign iconPlus sign icon
ZARS Pharma's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ZARS Pharma have currently?

Minus sign iconPlus sign icon
As of December 2025, ZARS Pharma has approximately 51 employees across 3 continents, including North AmericaAfricaAsia. Key team members include Chairman: T. S.Owner: W. H.VP, Regulatory Affairs: P. R.. Explore ZARS Pharma's employee directory with LeadIQ.

What industry does ZARS Pharma belong to?

Minus sign iconPlus sign icon
ZARS Pharma operates in the Pharmaceutical Manufacturing industry.

What is ZARS Pharma's email format?

Minus sign iconPlus sign icon
ZARS Pharma's email format typically follows the pattern of FLast@zars.com. Find more ZARS Pharma email formats with LeadIQ.

When was ZARS Pharma founded?

Minus sign iconPlus sign icon
ZARS Pharma was founded in 1996.

ZARS Pharma

Pharmaceutical ManufacturingUtah, United States51-200 Employees

ZARS Pharma is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs using our proprietary drug delivery technologies, primarily in the area of pain management.

ZARS has two approved products and many more in various stages of development.

Synera® (lidocaine 70mg/tetracaine 70mg topical patch) is a topical patch designed to provide local dermal anesthesia for potentially painful superficial procedures, such as venous access procedures involving needles and immunization injections of children. Synera uses our CHADD® technology and a proprietary local anesthetic formulation that contains lidocaine and tetracaine. We are commercializing Synera in the United States and our partner, EuroCept, markets Synera (named Rapydan) in Europe.

Synera resembles a small adhesive bandage in appearance and is applied to the skin before painful medical procedures such as venous access, blood draws, needle injections and minor dermatologic surgical procedures.  Synera is applied for 20 to 30 minutes prior to venous access procedures and needle injections and for 30 minutes prior to minor dermatological procedures. www.synera.com. 

Pliaglis® is a topical local anesthetic cream that provides safe and effective local dermal anesthesia on intact skin prior to painful cosmetic procedures such as dermatologic laser surgery and dermal filler injections. This product consists of a proprietary formulation of lidocaine and tetracaine that utilizes our Peel technology.  Pliaglis should be applied for 20-30 minutes prior to minor dermatological procedures, such as a dermal filler injections, and for 60 minutes prior to major dermatological procedures, such as laser-assisted tattoo removal. Following the application period, Pliaglis can easily be removed from the skin and the procedure can be performed.  Pliaglis is approved by the FDA.  Galderma owns the worldwide marketing rights to the product.

Section iconCompany Overview

Phone number
Website
zars.com
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1996
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $10M$25M

    ZARS Pharma's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    ZARS Pharma's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.